These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vasopressor dosing in septic shock. Alaniz C, Pollard S. Crit Care Med; 2013 Dec; 41(12):e483-4. PubMed ID: 24275412 [No Abstract] [Full Text] [Related]
3. Norepinephrine vs. dopamine: new recommendations for initial vasopressor selection in septic shock. Bartel B. S D Med; 2014 May; 67(5):200-1. PubMed ID: 24851468 [No Abstract] [Full Text] [Related]
4. The Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. An assessment by the Australian and New Zealand intensive care society. Hicks P, Cooper DJ, Webb S, Myburgh J, Seppelt I, Peake S, Joyce C, Stephens D, Turner A, French C, Hart G, Jenkins I, Burrell A. Anaesth Intensive Care; 2008 Mar; 36(2):149-51. PubMed ID: 18361003 [No Abstract] [Full Text] [Related]
5. Less is more: catecholamine-sparing strategies in septic shock. Venkatesh B, Khanna AK, Cohen J. Intensive Care Med; 2019 Dec; 45(12):1810-1812. PubMed ID: 31520103 [No Abstract] [Full Text] [Related]
6. Comparison of dopamine and norepinephrine in shock. Romero CM. N Engl J Med; 2010 Jun 17; 362(24):2328; author reply 2330-1. PubMed ID: 20554990 [No Abstract] [Full Text] [Related]
7. Vasoactive drug support in septic shock. Dries DJ. Shock; 2006 Nov 17; 26(5):529-30. PubMed ID: 17047528 [No Abstract] [Full Text] [Related]
8. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials. Vasu TS, Cavallazzi R, Hirani A, Kaplan G, Leiby B, Marik PE. J Intensive Care Med; 2012 Nov 17; 27(3):172-8. PubMed ID: 21436167 [Abstract] [Full Text] [Related]
9. Vasopressors for hypotensive shock. Lampard JG, Lang E. Ann Emerg Med; 2013 Mar 17; 61(3):351-2. PubMed ID: 23026787 [No Abstract] [Full Text] [Related]
10. [Basic principles of the therapy of shock]. Schröder R. Minerva Med; 1972 Dec 26; 63(93):5243-6. PubMed ID: 4646406 [No Abstract] [Full Text] [Related]
11. Noradrenaline as a vasoactive agent in septic shock. Tordoff SG, Thompson JL, Williams AW. Intensive Care Med; 2000 May 26; 26(5):648. PubMed ID: 10923747 [No Abstract] [Full Text] [Related]
12. Comparison of dopamine and norepinephrine in shock. Du B, Hu X, Weng L. N Engl J Med; 2010 Jun 17; 362(24):2330; author reply 2330-1. PubMed ID: 20560182 [No Abstract] [Full Text] [Related]
13. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study). Póvoa PR, Carneiro AH, Ribeiro OS, Pereira AC, Portuguese Community-Acquired Sepsis Study Group. Crit Care Med; 2009 Feb 17; 37(2):410-6. PubMed ID: 19114885 [Abstract] [Full Text] [Related]
14. Comparison of dopamine and norepinephrine in shock. Paolo WF. N Engl J Med; 2010 Jun 17; 362(24):2330; author reply 2330-1. PubMed ID: 20560161 [No Abstract] [Full Text] [Related]
15. Dopamine versus norepinephrine in the treatment of shock. Nathan Coxford R, Lang E, Dowling S. CJEM; 2011 Nov 17; 13(6):395-7. PubMed ID: 22436478 [Abstract] [Full Text] [Related]